Ceftolozane/Tazobactam Treatment of Multidrug-resistant Pseudomonas aeruginosa Infections in Children

Leah Molloy, Ibrahim Abdulhamid, Ruma Srivastava, Jocelyn Y. Ang

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The clinical use, safety and effectiveness of ceftolozane/tazobactam among 13 patients 3 months to 19 years of age infected with multidrug-resistant Pseudomonas aeruginosa are described. All but one patient achieved clinical cure after initial treatment. Adverse drug events attributed to treatment included transaminitis and neutropenia which occurred in 2 patients and resolved upon dose reduction.

Original languageEnglish
Pages (from-to)419-420
Number of pages2
JournalPediatric Infectious Disease Journal
Volume39
Issue number5
DOIs
StatePublished - May 1 2020

Keywords

  • Pseudomonas aeruginosa
  • ceftolozane/tazobactam
  • multidrug-resistant

Fingerprint

Dive into the research topics of 'Ceftolozane/Tazobactam Treatment of Multidrug-resistant Pseudomonas aeruginosa Infections in Children'. Together they form a unique fingerprint.

Cite this